Clincosm LogoSign in Get a demo

Cardiovascular Diseases

Showing NaN - NaN of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure, Cardiovascular Diseases Trial in Worldwide (NT-proBNP)

Recruiting
  • Heart Failure
  • Cardiovascular Diseases
  • NT-proBNP
  • Cleveland, Ohio
  • +6 more
Jun 22, 2023

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Inflammation, Cardiovascular Diseases, Zinc Deficiency Trial in Cleveland (Zinc Gluconate, Placebo)

Recruiting
  • Inflammation
  • +2 more
  • Zinc Gluconate
  • Placebo
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jan 8, 2023

Stroke, Cerebrovascular Disorders, Brain Diseases Trial in Cleveland (Aerobic Exercise, Upper Extremity Repetitive Task

Active, not recruiting
  • Stroke
  • +6 more
  • Aerobic Exercise
  • Upper Extremity Repetitive Task Practice
  • Cleveland, Ohio
    Cleveland Clinic Main Campus
Dec 20, 2022

Cardiovascular Diseases, Heart Failure, Ischemic Heart Disease Trial in Cleveland (MRI)

Recruiting
  • Cardiovascular Diseases
  • +9 more
  • MRI
  • Cleveland, Ohio
    Cardiovascular Innovation Research Center
Dec 7, 2022

Hypogonadism, Cardiovascular Diseases Trial in Puerto Rico, United States (Testosterone, Placebo)

Completed
  • Hypogonadism
  • Cardiovascular Diseases
  • Alabaster, Alabama
  • +383 more
Dec 13, 2022

CV Imaging of Metabolic Interventions

Recruiting
  • Bariatric Surgery Candidate
  • +2 more
  • MRI
  • Cleveland, Ohio
    Cardiovascular Innovation Research Center
Dec 5, 2022

Vascular Lab Resource (VLR) Biorepository

Recruiting
  • Cardiovascular Diseases
  • +15 more
    • Cleveland, Ohio
      Cleveland Clinic
    Nov 16, 2022

    COMPASSION XT PAS - Post-approval Study of SAPIEN XT THV in

    Active, not recruiting
    • Pulmonary Valve Insufficiency
    • +5 more
    • SAPIEN XT THV
    • Birmingham, Alabama
    • +11 more
    Oct 24, 2022

    Immune Activation and Cardiovascular Risk in HIV

    Active, not recruiting
    • HIV Infection
    • +2 more
    • Cleveland, Ohio
    • +1 more
    Sep 20, 2022

    (DCRI Central and Statistical Coordinating Center)

    Completed
    • HIV/AIDS
    • Cardiovascular Diseases
      • Durham, North Carolina
      • +4 more
      Aug 19, 2022

      Continuation of the nuMoM2b Heart Health Study

      Not yet recruiting
      • Cardiovascular Diseases
        • Orange, California
        • +13 more
        Jul 21, 2022

        Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency Trial in Canada, United States (Tendyne Mitral Valve

        Recruiting
        • Mitral Regurgitation
        • +7 more
        • Tendyne Mitral Valve System
        • MitraClip System
        • Birmingham, Alabama
        • +77 more
        Jun 13, 2022

        Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Worldwide (Paradise Renal Denervation System, Renal Angiogram)

        Active, not recruiting
        • Hypertension
        • +2 more
        • Paradise Renal Denervation System
        • Renal Angiogram
        • Birmingham, Alabama
        • +58 more
        Mar 28, 2022

        Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases Trial in Worldwide (Transcatheter Tricuspid Valve

        Recruiting
        • Tricuspid Valve Regurgitation
        • +2 more
        • Transcatheter Tricuspid Valve Replacement
        • Los Angeles, California
        • +24 more
        Feb 2, 2022

        Cardiovascular Diseases, Cardiovascular Risk Factors Trial in Worldwide

        Recruiting
        • Cardiovascular Diseases
        • Cardiovascular Risk Factors
          • Bethesda, Maryland
          • +35 more
          Dec 22, 2021

          Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency Trial in Worldwide (Carillon Mitral Contour System,

          Recruiting
          • Functional Mitral Regurgitation
          • +5 more
          • Carillon Mitral Contour System
          • Guideline Directed Heart Failure Medication
          • Gilbert, Arizona
          • +47 more
          Oct 10, 2021

          Cardiovascular Diseases, Statin Adverse Reaction Trial in Worldwide (Bempedoic acid 180 mg tablet, Matching tablet)

          Active, not recruiting
          • Cardiovascular Diseases
          • Statin Adverse Reaction
          • Bempedoic acid 180 mg tablet
          • Matching placebo tablet
          • Birmingham, Alabama
          • +1359 more
          Sep 7, 2021

          Cardiovascular Diseases Trial in United States (ABIOMED, Inc. hemodynamic support devices)

          Active, not recruiting
          • Cardiovascular Diseases
          • ABIOMED, Inc. hemodynamic support devices
          • Birmingham, Alabama
          • +50 more
          May 6, 2021

          Coronary Artery Disease, Coronary Disease, Myocardial Ischemia Trial in Israel, United States (CorPath-assisted Percutaneous

          Completed
          Has Results
          • Coronary Artery Disease
          • +7 more
          • CorPath-assisted Percutaneous Coronary Intervention
          • San Diego, California
          • +15 more
          Dec 1, 2020

          Stroke, Cerebrovascular Disorders, Nervous System Diseases Trial in Cleveland (rTMS Contralesional M1, rTMS Contralesional PMC,

          Completed
          • Stroke
          • +6 more
          • rTMS Contralesional M1
          • +3 more
          • Cleveland, Ohio
            Cleveland Clinic Foundation
          Jul 14, 2020

          Cardiovascular Diseases Trial in Cleveland (Facebook)

          Completed
          • Cardiovascular Diseases
          • Facebook
          • Cleveland, Ohio
            The Cleveland Clinic
          Mar 24, 2020

          Cardiovascular Diseases Trial in Worldwide (Evacetrapib, Placebo)

          Terminated
          Has Results
          • Cardiovascular Diseases
          • Birmingham, Alabama
          • +443 more
          Sep 25, 2019

          Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

          Completed
          Has Results
          • Diabetes Mellitus, Type 2
          • +2 more
          • Placebo
          • +2 more
          • Birmingham, Alabama
          • +312 more
          Nov 5, 2018

          Plaque Inflammation and Dysfunctional HDL in AIM-HIGH

          Completed
          • Cardiovascular Diseases
          • +4 more
          • Birmingham, Alabama
          • +28 more
          May 8, 2018